Advancements in Hepatology: Primary Biliary Cholangitis Therapeutic...

bir ses eklendi Health

2025-12-23 08:54:56 -

Advancements in Hepatology: Primary Biliary Cholangitis Therapeutic Market Growth Fueled by Novel PPAR Agonists

Primary Biliary Cholangitis (PBC), a chronic liver disease characterized by the progressive destruction of the bile ducts, is entering a new era of therapeutic intervention. For decades, Ursodeoxycholic Acid (UDCA) was the only line of defense, but nearly 40% of patients do not respond adequately to this treatment. This unmet medical need has sparked an intensive wave of innovation, focusing on...

0 Yorumlar 0 hisse senetleri 70 Views 0 önizleme